Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 57 | 1 | 53 | −3 |
| Shares | 5.72M | 100 | 4.79M | −930.5K (−16.3%) |
| Value | $11.5M | $206 | $928.4K | −$10.5M (−91.9%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GTS Securities LLC | 202,720 | $40.5K | 0.00% |
| Sabby Management, LLC | 136,484 | $27.3K | 0.09% |
| Group One Trading, L.P. | 97,088 | $19.4K | 0.00% |
| Two Sigma Securities, LLC | 40,279 | $8.06K | 0.00% |
| Jane Street Group, LLC | 30,563 | $6.12K | 0.00% |
| XTX Topco Ltd | 24,501 | $4.90K | 0.00% |
| AE Wealth Management LLC | 14,422 | $2.89K | 0.00% |
| Centennial Wealth Advisory LLC | 12,000 | $2.40K | 0.00% |
| HighTower Advisors, LLC | 10,465 | $2.00K | 0.00% |
Sold out (12)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| AIGH Capital Management LLC | 708,235 | $1.46M |
| Susquehanna International Group, LLP | 505,799 | $1.04M |
| Worth Venture Partners, LLC | 175,563 | $361.7K |
| Marshall Wace, LLP | 67,418 | $138.9K |
| Citadel Advisors LLC | 40,956 | $84.4K |
| Occudo Quantitative Strategies LP | 24,395 | $50.3K |
| Boothbay Fund Management, LLC | 19,098 | $39.3K |
| Kingswood Wealth Advisors, LLC | 16,600 | $34.2K |
| Wolverine Trading, LLC | 13,451 | $26.9K |
| Connor, Clark & Lunn Investment Management Ltd. | 11,861 | $24.4K |
| Virtu Financial LLC | 10,884 | $22.0K |
| NewSquare Capital LLC | 70 | $144 |
Not filed for Q3 2023 yet (1)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Piershale Financial Group, Inc. | 100 | $206 |